Comments: |
Iowa Neonatal Screening Program protocol detects primary
hypothyroidism, galactosemia, hemoglobin disorders, and congenital
adrenal hyperplasia.
Effective 9/3/05, the Iowa Neonatal Screening Program offers an
Expanded Screening Disorders:
ABNORMAL ANALYTES: Analytes refer to amino acids: [(ARG) Arginine,
(ASA) Argininosuccinic Aciduria, (CIT) Citrulline, (LEU) Leucine, (MAA)
Multiple Amino Acids, (MET) Methionine, (PHE) Phenylalanine, (TPN)
Total Parenteral Nutrition, (TYR) Tyrosine, (VAL)Valine] and
acylcarnitines: [LOW C0, HI C0, C3, C3-DC, C4, C4-OH, C5, C5:1, C5-DC,
C5-OH, C6, C6-DC, C8, C10, C10:1, C14, C14:1, C16, C16-OH, C16-OH/C16,
C0/C16, C16:1-OH, C18-OH, C18:1, C18:1-OH, (MAC) multiple
acylcarnitines] that are outside normal range limits.
UHL requisition form MUST have the following information completed on
the form before delivery to laboratory: Collector's initials, infant's
last name and first name, sex, first or repeat specimen, physician
name, date and time of birth, feeding method (bottle/breast/NPO/
parenteral nutrition), mother's first and last name, mother's date of
birth, date and time of collection, weight at time of collection,
gestational age in weeks, transfusion within the last eight weeks and
date of transfusion. |